In SMA mice, treatment of animals with a potassium channel blocker that increases neuronal activity improves motor function116, and treatment with Roscovitine that enhances Ca2+ influx and transmitter release beneficially affects the survival of SMA mice65. This evidence concerns the gene KCNA3 and proximal spinal muscular atrophy.